Status:
COMPLETED
Effectiveness of Orthokeratology in Myopia Control
Lead Sponsor:
Illinois College of Optometry
Collaborating Sponsors:
Wesley Research Institute
Conditions:
Myopia
Eligibility:
All Genders
6-13 years
Phase:
NA
Brief Summary
The high prevalence of myopia - especially in Asian countries - is well documented, as are the sight-threatening complications of high or degenerative myopia. Retinal detachment, glaucoma, vitreal deg...
Detailed Description
Orthokeratology (ortho-k), when used for partial or full correction of myopia, has been shown to slow myopic progression in children by 36-56% as compared to their spectacle or contact-lens wearing pe...
Eligibility Criteria
Inclusion
- myopia progression more than -1.00D in one year
- myopic prescription between -1.00D and -6.00D in at least one eye with refractive astigmatism \<1.50D
- Best corrected VA 20/25 or better
- subjects willing to present to clinic for all necessary follow up care
- willing to be randomized to either group
Exclusion
- non-compliance with treatment protocol
- contraindications for orthok as per company guidelines
- history of refractive surgery
- current gas permeable contact lens wearers
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03465748
Start Date
May 1 2017
End Date
December 1 2021
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Illinois Eye Institute
Chicago, Illinois, United States, 60616